André Planting

Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer.

Melanie Mackean, André Planting, Chris Twelves et al. · Journal of Clinical Oncology · 1998 · 268 citations

Medicine, Oncology, Pharmacology +15

A phase I dose escalation study of BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on, 2-week off schedule in patients with advanced solid tumours

F. Eskens, Constantijne H. Mom, André Planting et al. · British Journal of Cancer · 2007 · 231 citations · Full text

Medicine, Oncology, Pharmacology +17

Cigarette Smoking and Irinotecan Treatment: Pharmacokinetic Interaction and Effects on Neutropenia

Jessica M. van der Bol, Ron H.J. Mathijssen, Walter J. Loos et al. · Journal of Clinical Oncology · 2007 · 127 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Body-Surface Area–Based Dosing Does Not Increase Accuracy of Predicting Cisplatin Exposure

Felix E. de Jongh, Jaap Verweij, Walter J. Loos et al. · Journal of Clinical Oncology · 2001 · 122 citations

Medicine, Pharmacokinetics, Pharmacology +14

An EORTC Gastrointestinal Group evaluation of the combination of sequential methotrexate and 5-fluorouracil, combined with adriamycin in advanced measurable gastric cancer.

J. Wils, Harry Bleiberg, O. Dalesio et al. · Journal of Clinical Oncology · 1986 · 114 citations

Pharmacy, Oncology, Pharmacotherapy +15